Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Business Update
Bioscience company converts silver dihydrogen citrate manufacturing space
February 3rd, 2005
PURE Bioscience (OTCBB:PURE) announced that it will begin conversion of part of its existing manufacturing space to a dedicated U.S. Food and Drug Administration (FDA) compliant current good manufacturing practices (cGMP) facility for the production of pharmaceutical grade silver dihydrogen citrate. Michael L. Krall, president and CEO of PURE Bioscience, stated, "As we move forward with testing and regulatory work on silver dihydrogen citrate for use in prescription and personal care products, we are required to produce silver dihydrogen citrate raw material in compliance with the FDA's good manufacturing practices. Fortunately, the space required to produce silver...
Source: Women's Health Weekly (2005-02-03)
|
